Regulations

Trump eases marijuana regulations amid industry backing, Catholic concerns #Catholic President Donald Trump signed an executive order Dec. 18, 2025, that eases federal marijuana regulations amid support from the cannabis industry but opposition from some Catholic and conservative groups. / Credit: Justin Sullivan/Getty Images Washington, D.C. Newsroom, Dec 18, 2025 / 17:18 pm (CNA). President Donald Trump on Thursday signed an executive order to ease federal marijuana regulations amid support from the cannabis industry but opposition from some Catholic and conservative groups.Trump’s Dec. 18 executive order directs the attorney general to reclassify marijuana from a Schedule I drug to a Schedule III drug as quickly as federal law allows. This process began under President Joe Biden’s administration and is being continued under Trump.Schedule I, which includes marijuana, is reserved for drugs that have “no currently accepted medical use and a high potential for abuse,” according to the Drug Enforcement Agency (DEA). Schedule III is a lower classification, which is for drugs “with a moderate to low potential for physical and psychological dependence” and less abuse potential than Schedule I.Rescheduling marijuana does not end a federal ban on both recreational and medical use, which would still be in place. However, it would reduce criminal penalties, open the door for medical research, and potentially be a step toward further deregulation and normalization.Right now, 40 states have medical marijuana programs and 24 legalize recreational use, in contrast to the federal law.In a news conference, Trump said rescheduling marijuana will help patients who seek the drug for medical use “live a far better life.” He said the executive order “in no way sanctions its use as a recreational drug.”“Young Americans are especially at risk, so unless a drug is recommended by a doctor for medical reasons, just don’t do it,” the president said.“At the same time, the facts compel the federal government to recognize that marijuana can be legitimate in terms of medical applications when carefully administered,” he said. “In some cases, this may include the use as a substitute for addictive and potentially lethal opioid painkillers.”Kelsey Reinhardt, president and CEO of CatholicVote, criticized the decision. The group had launched a campaign to discourage the president from rescheduling the product. “Every argument pushed by the cannabis lobby has now been exposed as false by real-world data and medical science,” Reinhardt said in a statement.“We were told marijuana was safe, nonaddictive, and would reduce crime — none of that turned out to be true in my home state of Colorado or in other states that are now working to repeal,” she said. “Instead, we’re seeing higher addiction rates, emergency-room spikes, impaired driving, heart risks, mental-health damage, and lasting harm to young people,” Reinhardt said.Reinhardt called the executive order “disappointing” and said it “repeats the same reckless mistakes we made with Big Tobacco and puts ideology ahead of public health.” She said CatholicVote will work with federal agencies to “minimize the damage” and urged Congress to take action to reverse the executive order. The Catechism of the Catholic Church does not directly mention marijuana but teaches “the use of drugs inflicts very grave damage on human health and life.” It calls drug use a “grave offense” with the exception of drugs used on “strictly therapeutic grounds,” such as medical treatment.In spite of concerns from some Catholics, some Catholic hospitals have done research into medical marijuana. Some of that research has looked into medical marijuana as potentially a less risky and less addictive alternative to opioids for pain management.The United States Conference of Catholic Bishops has not taken a position on the matter. Pope Francis said he opposed the partial legalization of so-called “soft drugs,” stating in 2014 that “the problem of drug use is not solved with drugs.” In June, Pope Leo XIV referred to drugs as “an invisible prison” and encouraged law enforcement to focus on drug traffickers instead of addicts. 
Read More

Trump eases marijuana regulations amid industry backing, Catholic concerns #Catholic President Donald Trump signed an executive order Dec. 18, 2025, that eases federal marijuana regulations amid support from the cannabis industry but opposition from some Catholic and conservative groups. / Credit: Justin Sullivan/Getty Images Washington, D.C. Newsroom, Dec 18, 2025 / 17:18 pm (CNA). President Donald Trump on Thursday signed an executive order to ease federal marijuana regulations amid support from the cannabis industry but opposition from some Catholic and conservative groups.Trump’s Dec. 18 executive order directs the attorney general to reclassify marijuana from a Schedule I drug to a Schedule III drug as quickly as federal law allows. This process began under President Joe Biden’s administration and is being continued under Trump.Schedule I, which includes marijuana, is reserved for drugs that have “no currently accepted medical use and a high potential for abuse,” according to the Drug Enforcement Agency (DEA). Schedule III is a lower classification, which is for drugs “with a moderate to low potential for physical and psychological dependence” and less abuse potential than Schedule I.Rescheduling marijuana does not end a federal ban on both recreational and medical use, which would still be in place. However, it would reduce criminal penalties, open the door for medical research, and potentially be a step toward further deregulation and normalization.Right now, 40 states have medical marijuana programs and 24 legalize recreational use, in contrast to the federal law.In a news conference, Trump said rescheduling marijuana will help patients who seek the drug for medical use “live a far better life.” He said the executive order “in no way sanctions its use as a recreational drug.”“Young Americans are especially at risk, so unless a drug is recommended by a doctor for medical reasons, just don’t do it,” the president said.“At the same time, the facts compel the federal government to recognize that marijuana can be legitimate in terms of medical applications when carefully administered,” he said. “In some cases, this may include the use as a substitute for addictive and potentially lethal opioid painkillers.”Kelsey Reinhardt, president and CEO of CatholicVote, criticized the decision. The group had launched a campaign to discourage the president from rescheduling the product. “Every argument pushed by the cannabis lobby has now been exposed as false by real-world data and medical science,” Reinhardt said in a statement.“We were told marijuana was safe, nonaddictive, and would reduce crime — none of that turned out to be true in my home state of Colorado or in other states that are now working to repeal,” she said. “Instead, we’re seeing higher addiction rates, emergency-room spikes, impaired driving, heart risks, mental-health damage, and lasting harm to young people,” Reinhardt said.Reinhardt called the executive order “disappointing” and said it “repeats the same reckless mistakes we made with Big Tobacco and puts ideology ahead of public health.” She said CatholicVote will work with federal agencies to “minimize the damage” and urged Congress to take action to reverse the executive order. The Catechism of the Catholic Church does not directly mention marijuana but teaches “the use of drugs inflicts very grave damage on human health and life.” It calls drug use a “grave offense” with the exception of drugs used on “strictly therapeutic grounds,” such as medical treatment.In spite of concerns from some Catholics, some Catholic hospitals have done research into medical marijuana. Some of that research has looked into medical marijuana as potentially a less risky and less addictive alternative to opioids for pain management.The United States Conference of Catholic Bishops has not taken a position on the matter. Pope Francis said he opposed the partial legalization of so-called “soft drugs,” stating in 2014 that “the problem of drug use is not solved with drugs.” In June, Pope Leo XIV referred to drugs as “an invisible prison” and encouraged law enforcement to focus on drug traffickers instead of addicts. 

unitedyam

President Donald Trump signed an executive order Dec. 18, 2025, that eases federal marijuana regulations amid support from the cannabis industry but opposition from some Catholic and conservative groups. / Credit: Justin Sullivan/Getty Images

Washington, D.C. Newsroom, Dec 18, 2025 / 17:18 pm (CNA).

President Donald Trump on Thursday signed an executive order to ease federal marijuana regulations amid support from the cannabis industry but opposition from some Catholic and conservative groups.

Trump’s Dec. 18 executive order directs the attorney general to reclassify marijuana from a Schedule I drug to a Schedule III drug as quickly as federal law allows. This process began under President Joe Biden’s administration and is being continued under Trump.

Schedule I, which includes marijuana, is reserved for drugs that have “no currently accepted medical use and a high potential for abuse,” according to the Drug Enforcement Agency (DEA). Schedule III is a lower classification, which is for drugs “with a moderate to low potential for physical and psychological dependence” and less abuse potential than Schedule I.

Rescheduling marijuana does not end a federal ban on both recreational and medical use, which would still be in place. However, it would reduce criminal penalties, open the door for medical research, and potentially be a step toward further deregulation and normalization.

Right now, 40 states have medical marijuana programs and 24 legalize recreational use, in contrast to the federal law.

In a news conference, Trump said rescheduling marijuana will help patients who seek the drug for medical use “live a far better life.” He said the executive order “in no way sanctions its use as a recreational drug.”

“Young Americans are especially at risk, so unless a drug is recommended by a doctor for medical reasons, just don’t do it,” the president said.

“At the same time, the facts compel the federal government to recognize that marijuana can be legitimate in terms of medical applications when carefully administered,” he said. “In some cases, this may include the use as a substitute for addictive and potentially lethal opioid painkillers.”

Kelsey Reinhardt, president and CEO of CatholicVote, criticized the decision. The group had launched a campaign to discourage the president from rescheduling the product. 

“Every argument pushed by the cannabis lobby has now been exposed as false by real-world data and medical science,” Reinhardt said in a statement.

“We were told marijuana was safe, nonaddictive, and would reduce crime — none of that turned out to be true in my home state of Colorado or in other states that are now working to repeal,” she said. “Instead, we’re seeing higher addiction rates, emergency-room spikes, impaired driving, heart risks, mental-health damage, and lasting harm to young people,” Reinhardt said.

Reinhardt called the executive order “disappointing” and said it “repeats the same reckless mistakes we made with Big Tobacco and puts ideology ahead of public health.” She said CatholicVote will work with federal agencies to “minimize the damage” and urged Congress to take action to reverse the executive order. 

The Catechism of the Catholic Church does not directly mention marijuana but teaches “the use of drugs inflicts very grave damage on human health and life.” It calls drug use a “grave offense” with the exception of drugs used on “strictly therapeutic grounds,” such as medical treatment.

In spite of concerns from some Catholics, some Catholic hospitals have done research into medical marijuana. Some of that research has looked into medical marijuana as potentially a less risky and less addictive alternative to opioids for pain management.

The United States Conference of Catholic Bishops has not taken a position on the matter. Pope Francis said he opposed the partial legalization of so-called “soft drugs,” stating in 2014 that “the problem of drug use is not solved with drugs.” In June, Pope Leo XIV referred to drugs as “an invisible prison” and encouraged law enforcement to focus on drug traffickers instead of addicts. 

Read More
HHS announces actions to restrict ‘sex-rejecting procedures’ on minors #Catholic President Donald J. Trump watches as Robert F. Kennedy Jr., Health and Human Services Secretary, speaks after being sworn in on Thursday, Feb. 13, 2025, in Washington, D.C. / Credit: Jabin Botsford/The Washington Post via Getty Images Washington, D.C. Newsroom, Dec 18, 2025 / 13:31 pm (CNA). The Department of Health and Human Services (HHS) proposed regulations today that would seek to end “sex-rejecting procedures” on anyone younger than 18 years old, which includes restrictions on hospitals and retailers.Under one proposal, the Centers for Medicare & Medicaid Services (CMS) would withhold all funding through Medicare and Medicaid to any hospital that offers surgeries or drugs to minors as a means to make them resemble the opposite sex. The proposed rules would prohibit federal Medicaid funding for “sex-rejecting procedures” on anyone under 18 and prohibit federal Children’s Health Insurance program (CHIP) funding for the procedures on anyone under 19.This includes surgical operations, such as the removal of healthy genitals to replace them with artificial genitals that resemble the opposite sex and chest procedures that remove the healthy breasts on girls or implant prosthetic breasts on boys.It also includes hormone treatments that attempt to masculinize girls with testosterone and feminize boys with estrogen and puberty blockers, which delay a child’s natural developments during puberty.HHS also announced that the Food and Drug Administration (FDA) is issuing warning letters to 12 manufacturers and retailers that they accuse of illegally marketing “breast binders” to girls under the age of 18 as a treatment for gender dysphoria. Breast binders compress breasts as a means to flatten them under their clothing.The news release said breast binders are Class 1 medical devices meant to help recover from cancer-related mastectomies, and the warning letters will “formally notify the companies of their significant regulatory violations and how they should take prompt corrective action.”Additionally, HHS is working to clarify the definition of a “disability” in civil rights regulations to exclude “gender dysphoria” that does not result from physical impairments. This ensures that discrimination laws are not interpreted in a way that would require “sex-rejecting procedures,” the statement said.HHS Secretary Robert F. Kennedy Jr. said in a news conference that “sex-rejecting procedures” on minors are “endangering the very lives that [doctors] are sworn to safeguard.”“So-called gender-affirming care has inflicted lasting physical and psychological damage on vulnerable young people,” he said. “This is not medicine — it is malpractice.” The proposals would conform HHS regulations to President Donald Trump’s Jan. 28 executive order to prohibit the “chemical and surgical mutilation” of children. The order instructed HHS to propose regulations to prevent these procedures on minors.In a news release, HHS repeatedly referred to the medical interventions as “sex-rejecting procedures” and warned they “cause irreversible damage, including infertility, impaired sexual function, diminished bone density, altered brain development, and other irreversible physiological effects.”HHS cited its own report from May, which found “deep uncertainty about the purported benefits of these interventions” for treating a minor with gender dysphoria. The report found that “these interventions carry risk of significant harms,” which can include infertility, sexual dysfunction, underdeveloped bone mass, cardiovascular disease, metabolic disorders, psychiatric disorders, and adverse cognitive impacts, among other complications.Stanley Goldfarb, chairman of Do No Harm, a medical advocacy group, said in a statement that the proposed regulation on hospitals is “another critical step to protect children from harmful gender ideology” and said he supports rules that ensure “American taxpayer dollars do not fund sex-change operations on minors.”“Many so-called gender clinics have already begun to close as the truth about the risks and long-term harms about these drugs and surgeries on minors have been exposed,” he said. “Now, hospitals that receive taxpayer funds from these federal programs must follow suit.”Mary Rice Hasson, director of the Person and Identity Project at the Ethics and Public Policy Center (EPPC), said she sees the proposed restriction on hospitals as “excellent.”“This proposed rule sends a powerful message to states and health care providers: It’s time to stop these unethical and dangerous procedures,” Hasson said. “Puberty is not a disease to be medicated away. All children have the right to grow and develop normally.”“Sex-rejecting procedures promise the impossible: that a child can escape the reality of being male or female,” she added. “In reality, these sex-rejecting procedures provide only the illusion of ‘changing sex’ by disabling healthy functions and altering the child’s healthy body through drugs and surgery that will cause lifelong harm.”In January, Bishop Robert Barron, chair of the United States Conference of Catholic Bishops’ (USCCB) Committee on Laity, Marriage, Family Life, and Youth, welcomed Trump’s executive action on these procedures, warning that they are “based on a false understanding of human nature, attempt to change a child’s sex.”“So many young people who have been victims of this ideological crusade have profound regrets over its life-altering consequences, such as infertility and lifelong dependence on costly hormone therapies that have significant side effects,” Barron said. “It is unacceptable that our children are encouraged to undergo destructive medical interventions instead of receiving access to authentic and bodily-unitive care.”
Read More

HHS announces actions to restrict ‘sex-rejecting procedures’ on minors #Catholic President Donald J. Trump watches as Robert F. Kennedy Jr., Health and Human Services Secretary, speaks after being sworn in on Thursday, Feb. 13, 2025, in Washington, D.C. / Credit: Jabin Botsford/The Washington Post via Getty Images Washington, D.C. Newsroom, Dec 18, 2025 / 13:31 pm (CNA). The Department of Health and Human Services (HHS) proposed regulations today that would seek to end “sex-rejecting procedures” on anyone younger than 18 years old, which includes restrictions on hospitals and retailers.Under one proposal, the Centers for Medicare & Medicaid Services (CMS) would withhold all funding through Medicare and Medicaid to any hospital that offers surgeries or drugs to minors as a means to make them resemble the opposite sex. The proposed rules would prohibit federal Medicaid funding for “sex-rejecting procedures” on anyone under 18 and prohibit federal Children’s Health Insurance program (CHIP) funding for the procedures on anyone under 19.This includes surgical operations, such as the removal of healthy genitals to replace them with artificial genitals that resemble the opposite sex and chest procedures that remove the healthy breasts on girls or implant prosthetic breasts on boys.It also includes hormone treatments that attempt to masculinize girls with testosterone and feminize boys with estrogen and puberty blockers, which delay a child’s natural developments during puberty.HHS also announced that the Food and Drug Administration (FDA) is issuing warning letters to 12 manufacturers and retailers that they accuse of illegally marketing “breast binders” to girls under the age of 18 as a treatment for gender dysphoria. Breast binders compress breasts as a means to flatten them under their clothing.The news release said breast binders are Class 1 medical devices meant to help recover from cancer-related mastectomies, and the warning letters will “formally notify the companies of their significant regulatory violations and how they should take prompt corrective action.”Additionally, HHS is working to clarify the definition of a “disability” in civil rights regulations to exclude “gender dysphoria” that does not result from physical impairments. This ensures that discrimination laws are not interpreted in a way that would require “sex-rejecting procedures,” the statement said.HHS Secretary Robert F. Kennedy Jr. said in a news conference that “sex-rejecting procedures” on minors are “endangering the very lives that [doctors] are sworn to safeguard.”“So-called gender-affirming care has inflicted lasting physical and psychological damage on vulnerable young people,” he said. “This is not medicine — it is malpractice.” The proposals would conform HHS regulations to President Donald Trump’s Jan. 28 executive order to prohibit the “chemical and surgical mutilation” of children. The order instructed HHS to propose regulations to prevent these procedures on minors.In a news release, HHS repeatedly referred to the medical interventions as “sex-rejecting procedures” and warned they “cause irreversible damage, including infertility, impaired sexual function, diminished bone density, altered brain development, and other irreversible physiological effects.”HHS cited its own report from May, which found “deep uncertainty about the purported benefits of these interventions” for treating a minor with gender dysphoria. The report found that “these interventions carry risk of significant harms,” which can include infertility, sexual dysfunction, underdeveloped bone mass, cardiovascular disease, metabolic disorders, psychiatric disorders, and adverse cognitive impacts, among other complications.Stanley Goldfarb, chairman of Do No Harm, a medical advocacy group, said in a statement that the proposed regulation on hospitals is “another critical step to protect children from harmful gender ideology” and said he supports rules that ensure “American taxpayer dollars do not fund sex-change operations on minors.”“Many so-called gender clinics have already begun to close as the truth about the risks and long-term harms about these drugs and surgeries on minors have been exposed,” he said. “Now, hospitals that receive taxpayer funds from these federal programs must follow suit.”Mary Rice Hasson, director of the Person and Identity Project at the Ethics and Public Policy Center (EPPC), said she sees the proposed restriction on hospitals as “excellent.”“This proposed rule sends a powerful message to states and health care providers: It’s time to stop these unethical and dangerous procedures,” Hasson said. “Puberty is not a disease to be medicated away. All children have the right to grow and develop normally.”“Sex-rejecting procedures promise the impossible: that a child can escape the reality of being male or female,” she added. “In reality, these sex-rejecting procedures provide only the illusion of ‘changing sex’ by disabling healthy functions and altering the child’s healthy body through drugs and surgery that will cause lifelong harm.”In January, Bishop Robert Barron, chair of the United States Conference of Catholic Bishops’ (USCCB) Committee on Laity, Marriage, Family Life, and Youth, welcomed Trump’s executive action on these procedures, warning that they are “based on a false understanding of human nature, attempt to change a child’s sex.”“So many young people who have been victims of this ideological crusade have profound regrets over its life-altering consequences, such as infertility and lifelong dependence on costly hormone therapies that have significant side effects,” Barron said. “It is unacceptable that our children are encouraged to undergo destructive medical interventions instead of receiving access to authentic and bodily-unitive care.”

unitedyam

President Donald J. Trump watches as Robert F. Kennedy Jr., Health and Human Services Secretary, speaks after being sworn in on Thursday, Feb. 13, 2025, in Washington, D.C. / Credit: Jabin Botsford/The Washington Post via Getty Images

Washington, D.C. Newsroom, Dec 18, 2025 / 13:31 pm (CNA).

The Department of Health and Human Services (HHS) proposed regulations today that would seek to end “sex-rejecting procedures” on anyone younger than 18 years old, which includes restrictions on hospitals and retailers.

Under one proposal, the Centers for Medicare & Medicaid Services (CMS) would withhold all funding through Medicare and Medicaid to any hospital that offers surgeries or drugs to minors as a means to make them resemble the opposite sex. The proposed rules would prohibit federal Medicaid funding for “sex-rejecting procedures” on anyone under 18 and prohibit federal Children’s Health Insurance program (CHIP) funding for the procedures on anyone under 19.

This includes surgical operations, such as the removal of healthy genitals to replace them with artificial genitals that resemble the opposite sex and chest procedures that remove the healthy breasts on girls or implant prosthetic breasts on boys.

It also includes hormone treatments that attempt to masculinize girls with testosterone and feminize boys with estrogen and puberty blockers, which delay a child’s natural developments during puberty.

HHS also announced that the Food and Drug Administration (FDA) is issuing warning letters to 12 manufacturers and retailers that they accuse of illegally marketing “breast binders” to girls under the age of 18 as a treatment for gender dysphoria. Breast binders compress breasts as a means to flatten them under their clothing.

The news release said breast binders are Class 1 medical devices meant to help recover from cancer-related mastectomies, and the warning letters will “formally notify the companies of their significant regulatory violations and how they should take prompt corrective action.”

Additionally, HHS is working to clarify the definition of a “disability” in civil rights regulations to exclude “gender dysphoria” that does not result from physical impairments. This ensures that discrimination laws are not interpreted in a way that would require “sex-rejecting procedures,” the statement said.

HHS Secretary Robert F. Kennedy Jr. said in a news conference that “sex-rejecting procedures” on minors are “endangering the very lives that [doctors] are sworn to safeguard.”

“So-called gender-affirming care has inflicted lasting physical and psychological damage on vulnerable young people,” he said. “This is not medicine — it is malpractice.” 

The proposals would conform HHS regulations to President Donald Trump’s Jan. 28 executive order to prohibit the “chemical and surgical mutilation” of children. The order instructed HHS to propose regulations to prevent these procedures on minors.

In a news release, HHS repeatedly referred to the medical interventions as “sex-rejecting procedures” and warned they “cause irreversible damage, including infertility, impaired sexual function, diminished bone density, altered brain development, and other irreversible physiological effects.”

HHS cited its own report from May, which found “deep uncertainty about the purported benefits of these interventions” for treating a minor with gender dysphoria. The report found that “these interventions carry risk of significant harms,” which can include infertility, sexual dysfunction, underdeveloped bone mass, cardiovascular disease, metabolic disorders, psychiatric disorders, and adverse cognitive impacts, among other complications.

Stanley Goldfarb, chairman of Do No Harm, a medical advocacy group, said in a statement that the proposed regulation on hospitals is “another critical step to protect children from harmful gender ideology” and said he supports rules that ensure “American taxpayer dollars do not fund sex-change operations on minors.”

“Many so-called gender clinics have already begun to close as the truth about the risks and long-term harms about these drugs and surgeries on minors have been exposed,” he said. “Now, hospitals that receive taxpayer funds from these federal programs must follow suit.”

Mary Rice Hasson, director of the Person and Identity Project at the Ethics and Public Policy Center (EPPC), said she sees the proposed restriction on hospitals as “excellent.”

“This proposed rule sends a powerful message to states and health care providers: It’s time to stop these unethical and dangerous procedures,” Hasson said. “Puberty is not a disease to be medicated away. All children have the right to grow and develop normally.”

“Sex-rejecting procedures promise the impossible: that a child can escape the reality of being male or female,” she added. “In reality, these sex-rejecting procedures provide only the illusion of ‘changing sex’ by disabling healthy functions and altering the child’s healthy body through drugs and surgery that will cause lifelong harm.”

In January, Bishop Robert Barron, chair of the United States Conference of Catholic Bishops’ (USCCB) Committee on Laity, Marriage, Family Life, and Youth, welcomed Trump’s executive action on these procedures, warning that they are “based on a false understanding of human nature, attempt to change a child’s sex.”

“So many young people who have been victims of this ideological crusade have profound regrets over its life-altering consequences, such as infertility and lifelong dependence on costly hormone therapies that have significant side effects,” Barron said. “It is unacceptable that our children are encouraged to undergo destructive medical interventions instead of receiving access to authentic and bodily-unitive care.”

Read More